CLINICAL_TRIALS
trial_result
· 2016-03-21
Clinical Trial Update: Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs [Phase 3]
Summary
A Phase 3 bioequipotency study comparing Idrabiotaparinux and Idraparinux in patients with Deep vein thrombosis of the lower limbs has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Deep Venous Thrombosis | Phase 3 | Status: COMPLETED